{"id":484160,"title":"Inspection Strategy for Canada's Access to Medicines Regime (POLICY-0055) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T23:07:23.774000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/inspection-strategy-canada-access-medicines-regime-0055.html?wbdisable=true","snippet":"Inspection Strategy for Canada's Access to Medicines Regime (POLICY-0055) December 1, 2007 Supersedes: New document Date issued: August 2007 Date of implementation: September 2007 Unit Name: Drug GMP Inspection Unit Telephone: 613-957-1492 Fax: 613-957-6709 Email:…","rawSnapshotUrl":"/api/snapshots/raw/484160","browseUrl":"https://replay.healtharchive.ca/job-6/20260106230723/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/inspection-strategy-canada-access-medicines-regime-0055.html?wbdisable=true#ha_snapshot=484160","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}